» Articles » PMID: 31572058

Phenyllactic Acid Promotes Cell Migration and Invasion in Cervical Cancer Via IKK/NF-κB-mediated MMP-9 Activation

Overview
Journal Cancer Cell Int
Publisher Biomed Central
Date 2019 Oct 2
PMID 31572058
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Persistent infection with high-risk human papillomavirus (hrHPV) is associated with cervical cancer development. This process involves the virus-encoded E6 and E7 oncoproteins, which are maintained and expressed during all malignant transformation stages. However, HPV alone is insufficient to drive tumor progression-related behaviors such as cervical cancer cell motility. In this study, we investigated the effect of phenyllactic acid (PLA), a phenolic acid phytochemical and biomarker for discriminating various cancers, on the metastatic potential of cervical cancer cells.

Methods: The effects of PLA on HPV16/18 E6/E7 expression, migratory and invasive behavior, and matrix metalloproteinases (MMPs) expression of cervical cancers cells were measured. Specific inhibitors were used to further investigate biological function and underlying mechanism of PLA modulated cell motility.

Results: PLA significantly promoted the migration and invasion of SiHa, HeLa, and C-33A cervical cancer cells as well as upregulated matrix metalloproteinase-9 (MMP-9) expression. Moreover, PLA treatment attenuated E6/E7 expression in SiHa and HeLa cells. Further molecular analysis showed that PLA activated the nuclear factor-kappa B (NF-κB) signaling pathway and increased the nuclear translocation of both IκBα and p65. Treating cervical cancer cells with an NF-κB inhibitor potently reversed PLA-induced migratory and invasive behavior, MMP-9 upregulation, and/or E6/E7 downregulation. The PLA-induced NF-κB activation and MMP-9 upregulation were mediated by IκB kinase-β (IKK-β) phosphorylation via PKC signals. The results suggested that SiHa, HeLa, and C-33A cells might undergo a similar process to enhance their motility in response to PLA, regardless of the HPV status.

Conclusions: Collectively, our study reveals a new biological function of PLA and elucidate the possible molecular role of PLA as a risk factor for triggering cervical cancer cell motility.

Citing Articles

Dysfunction in mitochondrial electron transport chain drives the pathogenesis of pulmonary arterial hypertension: insights from a multi-omics investigation.

Zhang X, Li J, Fu M, Geng X, Hu J, Tang K Respir Res. 2025; 26(1):29.

PMID: 39833797 PMC: 11749457. DOI: 10.1186/s12931-025-03099-8.


Recent advances in anti-inflammatory active components and action mechanisms of natural medicines.

Wu Z, Zhang T, Ma X, Guo S, Zhou Q, Zahoor A Inflammopharmacology. 2023; 31(6):2901-2937.

PMID: 37947913 DOI: 10.1007/s10787-023-01369-9.


Human papillomavirus associated cervical lesion: pathogenesis and therapeutic interventions.

Ye J, Zheng L, He Y, Qi X MedComm (2020). 2023; 4(5):e368.

PMID: 37719443 PMC: 10501338. DOI: 10.1002/mco2.368.


Enhancing prognostic accuracy in head and neck squamous cell carcinoma chemotherapy via a lipid metabolism-related clustered polygenic model.

Miao X, Wang H, Fan C, Song Q, Ding R, Wu J Cancer Cell Int. 2023; 23(1):164.

PMID: 37568192 PMC: 10422777. DOI: 10.1186/s12935-023-03014-5.


Strain-Level Dynamics Reveal Regulatory Roles in Atopic Eczema by Gut Bacterial Phages.

Chu Y, Meng Q, Yu J, Zhang J, Chen J, Kang Y Microbiol Spectr. 2023; :e0455122.

PMID: 36951555 PMC: 10101075. DOI: 10.1128/spectrum.04551-22.


References
1.
Patel D, Huang S, Baglia L, McCance D . The E6 protein of human papillomavirus type 16 binds to and inhibits co-activation by CBP and p300. EMBO J. 1999; 18(18):5061-72. PMC: 1171577. DOI: 10.1093/emboj/18.18.5061. View

2.
Kim K, Park H, Paik M, Ryu H, Oh K, Myung S . Gas chromatographic profiling and pattern recognition analysis of urinary organic acids from uterine myoma patients and cervical cancer patients. J Chromatogr B Biomed Sci Appl. 1998; 712(1-2):11-22. DOI: 10.1016/s0378-4347(98)00155-8. View

3.
Wasik A, Grabarek J, Pantovic A, Cieslar-Pobuda A, Asgari H, Bundgaard-Nielsen C . Reprogramming and carcinogenesis--parallels and distinctions. Int Rev Cell Mol Biol. 2014; 308:167-203. DOI: 10.1016/B978-0-12-800097-7.00005-1. View

4.
Byg L, Vidlund J, Vasiljevic N, Clausen D, Forslund O, Norrild B . NF-κB signalling is attenuated by the E7 protein from cutaneous human papillomaviruses. Virus Res. 2012; 169(1):48-53. DOI: 10.1016/j.virusres.2012.06.028. View

5.
Caberg J, Hubert P, Herman L, Herfs M, Roncarati P, Boniver J . Increased migration of Langerhans cells in response to HPV16 E6 and E7 oncogene silencing: role of CCL20. Cancer Immunol Immunother. 2008; 58(1):39-47. PMC: 11030152. DOI: 10.1007/s00262-008-0522-5. View